Randi Connor-Schuler Selected Research

baricitinib

1/2021

Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Randi Connor-Schuler Research Topics

Disease

2	Shock 12/2020 - 01/2018
1	Edema (Dropsy) 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	COVID-19 01/2021
1	Pulmonary Heart Disease (Cor Pulmonale) 12/2020
1	ST Elevation Myocardial Infarction 12/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019
1	Hypothyroidism 01/2019
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2018
1	Heart Arrest (Cardiac Arrest) 01/2018
1	Leptospirosis 08/2017
1	Weil Disease (Weil's Disease) 08/2017

Drug/Important Bio-Agent (IBA)

1	baricitinibIBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	TroponinIBA 12/2020
1	Thyroid HormonesIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2017

Therapy/Procedure

1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022
1	Therapeutics 01/2022
1	Embolectomy 01/2018